Millipore Sigma Vibrant Logo

481981 Nifedipine - CAS 21829-25-4 - Calbiochem

Relatively selective blocker of L-type Ca2+ channels.

Nifedipine - CAS 21829-25-4 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: L-Type Calcium Channel Blocker III

Primary Target: L-type Ca2+ channels
View Products on Sigmaaldrich.com
481981
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
21829-25-4C₁₇H₁₈N₂O₆

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
481981-250MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 250 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewRelatively selective blocker of L-type Ca2+ channels. One of the most extensively studied blockers of 1,4-dihydropyridine-type Ca2+ channels, and a pharmacologically-useful vasodilator. Induces apoptosis in human glioblastoma cells.
      Catalogue Number481981
      Brand Family Calbiochem®
      SynonymsL-Type Calcium Channel Blocker III
      References
      ReferencesReid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.
      Product Information
      CAS number21829-25-4
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₁₇H₁₈N₂O₆
      Chemical formulaC₁₇H₁₈N₂O₆
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetL-type Ca2+ channels
      Purity≥98% by UV
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSUS7975000
      Safety Information
      R PhraseR: 22

      Harmful if swallowed.
      S PhraseS: 36-26

      Wear suitable protective clothing.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      481981-250MG 04055977183443

      Documentation

      Nifedipine - CAS 21829-25-4 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Nifedipine - CAS 21829-25-4 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      481981

      Riferimenti bibliografici

      Panoramica delle referenze
      Reid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-May-2008 RFH
      SynonymsL-Type Calcium Channel Blocker III
      DescriptionRelatively selective blocker of L-type Ca2+ channels. One of the most extensively studied Ca2+ channel blockers of 1,4-dihydropyridine-type and a pharmacologically useful vasodilator. Induces apoptosis in human glioblastoma cells.
      FormYellow solid
      CAS number21829-25-4
      RTECSUS7975000
      Chemical formulaC₁₇H₁₈N₂O₆
      Structure formulaStructure formula
      Purity≥98% by UV
      SolubilityDMSO or Ethanol
      Storage Protect from light
      +15°C to +30°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 6528
      ReferencesReid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.